ES2113669T3 - Estimulacion del bronceado mediante fragmentos de adn. - Google Patents

Estimulacion del bronceado mediante fragmentos de adn.

Info

Publication number
ES2113669T3
ES2113669T3 ES94923371T ES94923371T ES2113669T3 ES 2113669 T3 ES2113669 T3 ES 2113669T3 ES 94923371 T ES94923371 T ES 94923371T ES 94923371 T ES94923371 T ES 94923371T ES 2113669 T3 ES2113669 T3 ES 2113669T3
Authority
ES
Spain
Prior art keywords
dna fragments
stimulate
preparations
mammal
presented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94923371T
Other languages
English (en)
Inventor
Barbara A Gilchrest
Mina Yaar
Mark S Eller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston University
Original Assignee
Boston University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston University filed Critical Boston University
Application granted granted Critical
Publication of ES2113669T3 publication Critical patent/ES2113669T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

SE PRESENTA UN METODO PARA ESTIMULAR LA PRODUCCION DE PIGMENTOS EN LA PIEL DE UN MAMIFERO, ASI COMO PARA PROTEGER A LA PIEL DE UN MAMIFERO CONTRA LOS DAÑOS CAUSADOS POR LOS ULTRAVIOLETAS. TAMBIEN SE PRESENTAN UN METODO PARA ESTIMULAR LA PRODUCCION DE PIGMENTOS EN LAS CELULAS DE MAMIFEROS, UN METODO PAR ESTIMULAR LA MELANOGENESIS EN LOS MELANOCITOS DE UN MAMIFERO Y UN MEDIO DE CULTIVO PARA ESTIMULAR LA PRODUCCION DE MELANINA. LAS PREPARACIONES UTILES EN LOS PRESENTES METODOS TAMBIEN SE PRESENTAN. LOS METODOS CONSISTEN EN ADMINISTRAR A LA EPIDERMIS O A LAS CELULAS FRAGMENTOS DE ADN, BIEN DE UN SOLO FILAMENTO O DE DOS, O UNA MEZCLA DE LOS MISMOS, O DESOXINUCLEOTIDOS, DINUCLEOTIDOS O DIMEROS DE DINUCLEOTIDOS, EN UN VEHICULO APROPIADO, TAL COMO UNA PREPARACION LIPOSOMAL O PROPILENGLICOL. LAS PREPARACIONES INCLUYEN FRAGMENTOS DE ADN, DESOXINUCLEOTIDOS, DINUCLEOTIDOS O DIMEROS DE DINUCLEOTIDOS Y UN VEHICULO DE SUMINISTRO APROPIADO, TAL COMO LIPOSOMAS O PROPILENGLICOL. LOS FRAGMENTOS DE ADN, LOS DESOXINUCLEOTIDOS O DINUCLEOTIDOS UTILIZADOS EN LOS METODOS O EN LAS PREPARACIONES SE PUEDE IRRADIAR CON ULTRAVIOLETAS. LAS PREPARACIONES SON UN AGENTE DE BRONCEADO INDEPENDIENTE DEL SOL O UN AGENTE ESTIMULADOR DE LA MELANOGENESIS.
ES94923371T 1993-07-07 1994-07-07 Estimulacion del bronceado mediante fragmentos de adn. Expired - Lifetime ES2113669T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/088,251 US5470577A (en) 1993-07-07 1993-07-07 Stimulation of tanning by DNA fragments or single-stranded DNA

Publications (1)

Publication Number Publication Date
ES2113669T3 true ES2113669T3 (es) 1998-05-01

Family

ID=22210275

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94923371T Expired - Lifetime ES2113669T3 (es) 1993-07-07 1994-07-07 Estimulacion del bronceado mediante fragmentos de adn.

Country Status (7)

Country Link
US (4) US5470577A (es)
EP (1) EP0706369B1 (es)
AU (1) AU678842B2 (es)
CA (1) CA2166530C (es)
DE (1) DE69407414T2 (es)
ES (1) ES2113669T3 (es)
WO (1) WO1995001773A1 (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3004695A (en) * 1994-07-08 1996-02-09 Apogen Nucleic acid filters
US20030032610A1 (en) * 1996-06-03 2003-02-13 Gilchrest Barbara A. Method to inhibit cell growth using oligonucleotides
US5955059A (en) * 1995-06-06 1999-09-21 Trustees Of Boston University Use of locally applied DNA fragments
US7094766B1 (en) 1995-06-06 2006-08-22 Trustees Of Boston University Use of locally applied DNA fragments
US6147056A (en) * 1995-06-06 2000-11-14 Trustees Of Boston University Use of locally applied DNA fragments
JP3646191B2 (ja) 1996-03-19 2005-05-11 大塚製薬株式会社 ヒト遺伝子
US6214888B1 (en) * 1996-09-18 2001-04-10 Applied Genetics Incorporated Dermatological compounds
WO1998055085A1 (en) * 1997-06-04 1998-12-10 Codon Pharmaceuticals, Inc. Pharmaceutical compositions and methods
US6623724B2 (en) * 1996-09-18 2003-09-23 Applied Genetics Incorporated Dermatics Dermatological compositions and methods
CA2266496A1 (en) * 1996-09-18 1998-03-26 Codon Pharmaceuticals, Inc. Pharmaceutical compositions and methods
DK0952837T3 (da) 1996-11-28 2003-01-27 Cognis Deutschland Gmbh Anvendelse af blandinger af aktive stoffer indeholdende phytostenoler og/eller hydrostenolestere og forstærkere til fremstilling af hypocholesterolæmiske midler
US5800826A (en) * 1997-03-05 1998-09-01 E-L Management Corp. Sunscreen compositions containing damaged RNA fragments
US20020006913A1 (en) * 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
US6087341A (en) * 1998-02-12 2000-07-11 The Board Of Trustees Of The Leland Standford Junior University Introduction of nucleic acid into skin cells by topical application
US6267948B1 (en) 1998-04-06 2001-07-31 Applied Genetics Incorporated Dermatics Dermatological formulations and methods
DE19815086C2 (de) * 1998-04-06 2000-11-30 Cognis Deutschland Gmbh Sonnenschutzmittel
US20030113281A1 (en) * 1998-05-06 2003-06-19 Galderma Research & Development, S.N.C. Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay
IL138772A0 (en) * 1998-05-06 2001-10-31 Galderma Res & Dev Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay
WO2002051395A1 (en) * 1998-05-28 2002-07-04 Codon Pharmaceuticals, Inc. Treatment of neurodegenerative diseases
DE59905858D1 (de) 1998-07-16 2003-07-10 Cognis Deutschland Gmbh Verwendung von pit-emulsionen
JP2002541822A (ja) 1999-04-14 2002-12-10 エム ユー エス シー ファンデーション フォー リサーチ ディベロップメント 組織特異的および病原体特異的毒性物質ならびにリボザイム
EP1246532A2 (en) * 1999-06-07 2002-10-09 Mirus Corporation Delivery of single stranded dna for expression
WO2001049118A1 (en) * 2000-01-03 2001-07-12 Panagenic International, Inc. Compositions comprising genome segments and methods of using the same
DE10015363B4 (de) * 2000-03-23 2004-08-12 Coty B.V. Kosmetischer Kompakt- oder Cremepuder
EP1274410A2 (en) * 2000-03-31 2003-01-15 Trustees Of Boston University Use of locally applied dna fragments
AU2452302A (en) * 2000-07-21 2002-02-05 Mark B Lyles Sunscreen formulations containing nucleic acids
DE10150412A1 (de) * 2001-10-11 2003-04-17 Beiersdorf Ag Verwendung einer oder mehreren Substanzen, gewählt aus der Gruppe der Pyrimidine und Purine in kosmetischen Zubereitungen zur Bräunung der Haut
CA2491034A1 (en) * 2002-06-26 2004-01-08 The Penn State Research Foundation Methods and materials for treating human papillomavirus infections
FR2842105B1 (fr) * 2002-07-10 2012-12-28 Oreal Localisation des genes impliques dans la canitie precoce
FR2853532A1 (fr) * 2003-04-08 2004-10-15 Oreal Genes des chromosomes 6 et 9 impliques dans la canitie precoce
FR2842104B1 (fr) * 2002-07-10 2010-03-05 Oreal Genes impliques dans la canitie precoce
DE60325216D1 (de) * 2002-07-10 2009-01-22 Oreal Gene des chromosoms 9 und ihre assoziation zur frühzeitige haarergrauung
US7153691B2 (en) * 2002-11-13 2006-12-26 G6 Science Corp. Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents
US20060269924A1 (en) * 2003-04-11 2006-11-30 Trustees Of Boston University Modulation of telomere-initiated cell signaling
RU2234323C1 (ru) * 2003-05-27 2004-08-20 Шурдов Михаил Аркадьевич Препарат, обладающий противоопухолевым, антитоксическим и радиопротекторным действием
RU2313349C2 (ru) 2006-01-16 2007-12-27 Михаил Аркадьевич Шурдов Способ лечения онкологических заболеваний
CN101522179B (zh) * 2006-08-02 2013-01-02 李尹雄 增强型广谱uv辐射过滤剂及方法
FR2904550A1 (fr) * 2006-08-03 2008-02-08 Soc Extraction Principes Actif Utilisation d'un hydrolysat d'oeufs de salmonides en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes
CN101848702B (zh) 2006-12-01 2013-07-17 安特里奥公司 两亲实体纳米粒子
RU2345792C2 (ru) * 2007-04-03 2009-02-10 Михаил Аркадьевич Шурдов Способ лечения онкологических заболеваний
WO2008151022A2 (en) * 2007-05-31 2008-12-11 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
WO2009064493A1 (en) * 2007-11-14 2009-05-22 New York University School Of Medicine Tricyclic compounds as melanogenesis modifiers and uses thereof
WO2009064492A1 (en) * 2007-11-14 2009-05-22 New York University School Of Medicine Quinoline compounds as melanogenesis modifiers and uses thereof
JP2009275205A (ja) * 2008-04-17 2009-11-26 Fine Co Ltd 核酸を用いた紫外線吸収剤
US20100040568A1 (en) * 2008-04-30 2010-02-18 Skinmedica, Inc. Steroidal compounds as melanogenesis modifiers and uses thereof
DE102009044976A1 (de) * 2009-07-23 2011-01-27 Henkel Ag & Co. Kgaa Verwendung von Purin und/oder einem Purinderivat und mindestens einem Oligonukleotid zur Beeinflussung des natürlichen Pigmentierungsprozesses
DE102009044972A1 (de) * 2009-07-23 2011-01-27 Henkel Ag & Co. Kgaa Verwendung von mindestens einer Nukleinsäure zur Beeinflussung des natürlichen Pigmentierungsprozesses
FR2951938B1 (fr) 2009-10-30 2012-01-06 Oreal Utilisation d'un extrait de punica granatum pour lutter contre la canitie
WO2012103487A1 (en) 2011-01-27 2012-08-02 New York University Coumarin compounds as melanogenesis modifiers and uses thereof
FR2978659B1 (fr) 2011-08-05 2014-01-10 Oreal Utilisation de composes cannabinoides pour stimuler la melanogenese
US20130084326A1 (en) * 2011-10-03 2013-04-04 Bruce Howe Liposomes for the oral delivery of therapeutic agents
FR2999932B1 (fr) 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
FR2999931A1 (fr) 2012-12-21 2014-06-27 Oreal Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
EP3541358A1 (en) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Transdermal delivery of large agents
WO2020056191A1 (en) 2018-09-13 2020-03-19 Eirion Therapeutics, Inc. Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937809A (en) * 1974-05-01 1976-02-10 Kolmar Laboratories, Inc. Addition compound of a nucleotide and an amino acid and the use thereof in protection against actinic radiation
US4078052A (en) * 1976-06-30 1978-03-07 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Large unilamellar vesicles (LUV) and method of preparing same
FR2439013A1 (fr) * 1978-10-19 1980-05-16 Serobiologiques Lab Sa Composition, utilisable notamment comme produit cosmetique permettant un bronzage de la peau, comprenant l'emploi d'acides amines
FR2511243A1 (fr) * 1980-12-02 1983-02-18 Geskis Denise Gamme de produits cosmetiques et solaires a base d'a.d.n. hautement polymerise
DE3783541T2 (de) * 1986-02-03 1993-06-17 University Patents Inc Verfahren zur stimulierung von melanozyten durch lokales anbringen von alpha-msh-analogen, sowie zusammensetzungen.
JPS63183518A (ja) * 1986-09-18 1988-07-28 Lion Corp 毛髪用組成物
JPS63301810A (ja) * 1987-06-01 1988-12-08 Keikichi Sugiyama 毛髪用組成物
FR2621916B1 (fr) * 1987-10-19 1990-03-09 Bioeurope Derives de la l-tyrosine solubles dans l'eau et procede pour leur preparation
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
FR2623716B1 (fr) * 1987-11-27 1991-04-05 Lvmh Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la tyrosine ou un derive de tyrosine et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite pigmentante, l'incorporant
US5256648A (en) * 1988-01-21 1993-10-26 Yale University Selective inhibition of gene expression by photoactivatable oligonucleotides
AU5195090A (en) * 1989-03-07 1990-10-09 Plough Inc. Liposome compositions
IT1232318B (it) * 1989-09-07 1992-01-28 Crinos Industria Farmaco Composizioni ad uso topico contenenti acidi nucleici depolimerizzati per la cosmesi della pelle e del corpo.
CA2068427A1 (en) * 1989-11-09 1991-05-10 Patricia A. Agin Riboflavin as a tanning enhancer
US5135917A (en) * 1990-07-12 1992-08-04 Nova Pharmaceutical Corporation Interleukin receptor expression inhibiting antisense oligonucleotides
FR2668366B1 (fr) * 1990-10-30 1993-01-29 Oreal Utilisation cosmetique d'une composition ayant une activite antierythemale et composition correspondante.
US5352458A (en) * 1992-12-21 1994-10-04 Applied Genetics Inc. Tanning method using DNA repair liposomes

Also Published As

Publication number Publication date
US5643556A (en) 1997-07-01
US5470577A (en) 1995-11-28
DE69407414D1 (de) 1998-01-29
US5580547A (en) 1996-12-03
US5532001A (en) 1996-07-02
CA2166530C (en) 2006-10-17
CA2166530A1 (en) 1995-01-19
AU678842B2 (en) 1997-06-12
DE69407414T2 (de) 1998-07-09
EP0706369B1 (en) 1997-12-17
AU7325894A (en) 1995-02-06
EP0706369A1 (en) 1996-04-17
WO1995001773A1 (en) 1995-01-19

Similar Documents

Publication Publication Date Title
CA2166530A1 (en) Stimulation of tanning by dna fragments or single-stranded dna
ES2023890B3 (es) Estimulacion del crecimiento del cabello.
ATE260664T1 (de) Verwendung von lokalen applizierten dna- fragmenten
ATE209887T1 (de) Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikel
WO2004066947A3 (en) Hyperthermia oncolysis co-therapy
US20020120225A1 (en) Ultrasound enhancement of percutaneous drug absorption
DE3874813D1 (de) Zusammensetzung zur behandlung der haut.
ATE383893T1 (de) Verwendung von oligosacchariden zur stimulierung der produktion von beta-endorphin
BR0214009A (pt) Método e composição para estimular o crescimento de pelos sobre a pele
EP2263749A3 (en) Method and apparatus for the selective targeting of lipid-rich tissues
NZ334190A (en) Method for improved selectivity in photo-activation of molecular agents
BR9607894A (pt) Processo para tratar tumores
BR8701177A (pt) Processo para preparar uma composicao adequada para aplicacao topica a pele humana e processo para conversao do cabelo do couro para crescimento como cabelo terminal
RU94002358A (ru) Способ лечения диссеминированного псориаза
US5352458A (en) Tanning method using DNA repair liposomes
PT952772E (pt) Processos de utilizacao de fagocitos mononuclears para promover a regeneracao axonal
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
BR9002240A (pt) Processo para a preparacao de uma composicao conservada apropriada para aplicacao topica a pele e composicao
UA31314A (uk) Спосіб лікування облисіння та пристрій для його здійснення
ITVI940179A1 (it) Prodotti cosmetici per la protezione della pelle del viso e del corpo dai raggi solari.
UA31085A (uk) Спосіб лікування келоїдних рубців
AR003663A1 (es) Producto cosmetico capilar para la limpieza del cabello y cuero cabelludo y la remocion de piojos y liendres
IT1218617B (it) Trattamento per la crescita dei capelli
CN86200711U (zh) 健脑发梳

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 706369

Country of ref document: ES